Karyopharm Therapeutics
12 followers
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm... Read more
Org chart
Richard Paulson
President & CEO
Richard Paulson
Collapse
Sohanya Cheng
Chief Commercial Officer & Head of Business Development
Reshma Rangwala
Chief Medical Officer & Head of Research
Lisa DiPaolo
Chief Human Resources Officer
James Accumanno
Chief Compliance Officer
Stuart Poulton
Chief Development Officer
Mike Mano
SVP & General Counsel
Amama Sadiq
SVP, Global Medical & Scientific Affairs
Brian Austad
SVP, Pharmaceutical Sciences
Stephen Li
Senior Vice President, Regulatory Affairs
Kristin Abate
Vp, Accounting & Corporate Controller
Similar companies
Vanda Pharmaceutical
4 followers
Codexis
4 followers
Esperion Therapeutics
2 followers
Intra-Cellular Therapies
1 follower
Corcept Therapeutics
1 follower
Azzur Group
4 followers
SCA Pharma
1 follower
Catalent
15 followers
NYU Langone Health
12 followers
Mesa Labs
1 follower
PCI Pharma Services
6 followers
Discover companies